New Delhi: Hetero Company today announced the launch of ‘Covifor’, a prescription drug known to be a lifeline for coronavirus infections. The first stage is to sell 20 thousand drugs.
About 10 thousand of these drugs are being shipped to the most affected cities in Corona, including Delhi, Hyderabad, Tamil Nadu and Mumbai. The price of a 100 mg dose of injection through a human’s IV (intravenous) injection has been set at Rs 5,400.
Ayurvedic medicines and regular general medicine are being given to the coronavirus victims. Hetero has launched a special medicine for Corona.
Introduced under the name of CoviFor, the drug is a type of Gilead’s Remdesivir, a US pharmaceutical company. Remedesivir is approved by the European Drug Commission and the US Drug Regulatory Commission.
In this case, Hetero has introduced one of its kind in India. The Indian Pharmaceutical Regulatory Commission has given permission for the manufacture and sale of this drug on 13th.
Srinivasa Reddy, Managing Director of Hetero, told reporters: “’Covifor’, a life-saving drug of coronavirus patients, has been developed in conjunction with the advice of doctors in time of emergency.
In the first phase 20 thousand medicines are to be prepared and shipped. More than 10 thousand medicines are to be sent to cities including Mumbai, Delhi, Tamil Nadu, Gujarat and Hyderabad where coronavirus is most common.
The 2nd 10 thousand medicines will be sent to cities including Kolkata, Indore, Bhopal, Thiruvananthapuram, Ranchi, Bhubaneswar, Lucknow, Patna, Vijayawada, Cochin and Goa. We hope this will reduce the duration of treatment for patients if this drug is used only during this emergency.
The crisis for physicians will also decrease. We are constantly talking to central governments, state governments and medical professionals to make it available to all sorts of people.
Covifor, which is 100 milligrams, should be used only in emergency situations with the advice of doctors. We hope that this drug will definitely reduce the death toll. ”
‘Covifor’ is prescribed to be used by doctors in the last stage of coronary syndrome. The Ministry of Health has advised pregnant women, lactating mothers, children under the age of 12, people with chronic diseases to be diagnosed with lung disease and liver problems.